Antithrombotic effects of magnesium sulfate in in vivo experiments

Joen R. Sheu, George Hsiao, Ming Y. Shen, Yen M. Lee, Mao H. Yen

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

In this study, magnesium sulfate was effective in reducing the mortality of adenosine diphosphate-induced acute pulmonary thromboembolism in mice, when it was administered intravenously at doses of 100 and 200 μg/g body weight. In addition, intravenous injections of magnesium sulfate (100 and 200 μg/g) significantly prolonged bleeding time in the severed mesenteric arteries of rats by approximately 1.7- and 1.9-fold, respectively, compared with normal saline. Continuous infusion of magnesium sulfate (20 μg/g per minute) for 10 minutes also significantly increased the bleeding time by approximately 1.7-fold, and the bleeding time returned to baseline within 60 minutes of cessation of magnesium sulfate infusion. On the other hand, platelet thrombi formation was induced by irradiating mesenteric venules with filtered light in mice pretreated with intravenous fluorescein sodium. When magnesium sulfate was administered at 300 μg/g during induction of platelet plug formation with 10 μg/kg fluorescein sodium, occlusion time was not significantly prolonged, but a dose of 600 μg/g did significantly prolong the occlusion time. Furthermore, aspirin (250 μg/g) also showed a similar activity in this experiment in prolonging the occlusion time. In conclusion, these results suggest that magnesium sulfate has an effective antithrombotic activity in vivo, and treatment with magnesium sulfate may lower the risk of thromboembolic-related disorders.

Original languageEnglish
Pages (from-to)414-419
Number of pages6
JournalInternational Journal of Hematology
Volume77
Issue number4
Publication statusPublished - May 2003

Fingerprint

Magnesium Sulfate
Bleeding Time
Fluorescein
Blood Platelets
Mesenteric Arteries
Venules
Pulmonary Embolism
Intravenous Injections
Adenosine Diphosphate
Aspirin
Thrombosis
Body Weight
Light
Mortality

Keywords

  • Arterial thrombosis
  • Fluorescein sodium
  • Magnesium sulfate
  • Occlusion time
  • Platelet plug formation

ASJC Scopus subject areas

  • Hematology

Cite this

Antithrombotic effects of magnesium sulfate in in vivo experiments. / Sheu, Joen R.; Hsiao, George; Shen, Ming Y.; Lee, Yen M.; Yen, Mao H.

In: International Journal of Hematology, Vol. 77, No. 4, 05.2003, p. 414-419.

Research output: Contribution to journalArticle

Sheu, Joen R. ; Hsiao, George ; Shen, Ming Y. ; Lee, Yen M. ; Yen, Mao H. / Antithrombotic effects of magnesium sulfate in in vivo experiments. In: International Journal of Hematology. 2003 ; Vol. 77, No. 4. pp. 414-419.
@article{bbca90a320054d92b0829edb7e3fd782,
title = "Antithrombotic effects of magnesium sulfate in in vivo experiments",
abstract = "In this study, magnesium sulfate was effective in reducing the mortality of adenosine diphosphate-induced acute pulmonary thromboembolism in mice, when it was administered intravenously at doses of 100 and 200 μg/g body weight. In addition, intravenous injections of magnesium sulfate (100 and 200 μg/g) significantly prolonged bleeding time in the severed mesenteric arteries of rats by approximately 1.7- and 1.9-fold, respectively, compared with normal saline. Continuous infusion of magnesium sulfate (20 μg/g per minute) for 10 minutes also significantly increased the bleeding time by approximately 1.7-fold, and the bleeding time returned to baseline within 60 minutes of cessation of magnesium sulfate infusion. On the other hand, platelet thrombi formation was induced by irradiating mesenteric venules with filtered light in mice pretreated with intravenous fluorescein sodium. When magnesium sulfate was administered at 300 μg/g during induction of platelet plug formation with 10 μg/kg fluorescein sodium, occlusion time was not significantly prolonged, but a dose of 600 μg/g did significantly prolong the occlusion time. Furthermore, aspirin (250 μg/g) also showed a similar activity in this experiment in prolonging the occlusion time. In conclusion, these results suggest that magnesium sulfate has an effective antithrombotic activity in vivo, and treatment with magnesium sulfate may lower the risk of thromboembolic-related disorders.",
keywords = "Arterial thrombosis, Fluorescein sodium, Magnesium sulfate, Occlusion time, Platelet plug formation",
author = "Sheu, {Joen R.} and George Hsiao and Shen, {Ming Y.} and Lee, {Yen M.} and Yen, {Mao H.}",
year = "2003",
month = "5",
language = "English",
volume = "77",
pages = "414--419",
journal = "International Journal of Hematology",
issn = "0925-5710",
publisher = "Springer Japan",
number = "4",

}

TY - JOUR

T1 - Antithrombotic effects of magnesium sulfate in in vivo experiments

AU - Sheu, Joen R.

AU - Hsiao, George

AU - Shen, Ming Y.

AU - Lee, Yen M.

AU - Yen, Mao H.

PY - 2003/5

Y1 - 2003/5

N2 - In this study, magnesium sulfate was effective in reducing the mortality of adenosine diphosphate-induced acute pulmonary thromboembolism in mice, when it was administered intravenously at doses of 100 and 200 μg/g body weight. In addition, intravenous injections of magnesium sulfate (100 and 200 μg/g) significantly prolonged bleeding time in the severed mesenteric arteries of rats by approximately 1.7- and 1.9-fold, respectively, compared with normal saline. Continuous infusion of magnesium sulfate (20 μg/g per minute) for 10 minutes also significantly increased the bleeding time by approximately 1.7-fold, and the bleeding time returned to baseline within 60 minutes of cessation of magnesium sulfate infusion. On the other hand, platelet thrombi formation was induced by irradiating mesenteric venules with filtered light in mice pretreated with intravenous fluorescein sodium. When magnesium sulfate was administered at 300 μg/g during induction of platelet plug formation with 10 μg/kg fluorescein sodium, occlusion time was not significantly prolonged, but a dose of 600 μg/g did significantly prolong the occlusion time. Furthermore, aspirin (250 μg/g) also showed a similar activity in this experiment in prolonging the occlusion time. In conclusion, these results suggest that magnesium sulfate has an effective antithrombotic activity in vivo, and treatment with magnesium sulfate may lower the risk of thromboembolic-related disorders.

AB - In this study, magnesium sulfate was effective in reducing the mortality of adenosine diphosphate-induced acute pulmonary thromboembolism in mice, when it was administered intravenously at doses of 100 and 200 μg/g body weight. In addition, intravenous injections of magnesium sulfate (100 and 200 μg/g) significantly prolonged bleeding time in the severed mesenteric arteries of rats by approximately 1.7- and 1.9-fold, respectively, compared with normal saline. Continuous infusion of magnesium sulfate (20 μg/g per minute) for 10 minutes also significantly increased the bleeding time by approximately 1.7-fold, and the bleeding time returned to baseline within 60 minutes of cessation of magnesium sulfate infusion. On the other hand, platelet thrombi formation was induced by irradiating mesenteric venules with filtered light in mice pretreated with intravenous fluorescein sodium. When magnesium sulfate was administered at 300 μg/g during induction of platelet plug formation with 10 μg/kg fluorescein sodium, occlusion time was not significantly prolonged, but a dose of 600 μg/g did significantly prolong the occlusion time. Furthermore, aspirin (250 μg/g) also showed a similar activity in this experiment in prolonging the occlusion time. In conclusion, these results suggest that magnesium sulfate has an effective antithrombotic activity in vivo, and treatment with magnesium sulfate may lower the risk of thromboembolic-related disorders.

KW - Arterial thrombosis

KW - Fluorescein sodium

KW - Magnesium sulfate

KW - Occlusion time

KW - Platelet plug formation

UR - http://www.scopus.com/inward/record.url?scp=0141792762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141792762&partnerID=8YFLogxK

M3 - Article

C2 - 12774935

AN - SCOPUS:0141792762

VL - 77

SP - 414

EP - 419

JO - International Journal of Hematology

JF - International Journal of Hematology

SN - 0925-5710

IS - 4

ER -